Hadasit Bio (Israel) Performance

HDST Stock   42.20  2.20  5.50%   
Hadasit Bio holds a performance score of 8 on a scale of zero to a hundred. The company retains a Market Volatility (i.e., Beta) of 0.65, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Hadasit Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hadasit Bio is expected to be smaller as well. Use Hadasit Bio semi deviation, coefficient of variation, jensen alpha, as well as the relationship between the downside deviation and information ratio , to analyze future returns on Hadasit Bio.

Risk-Adjusted Performance

Fair

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Hadasit Bio are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Hadasit Bio sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Begin Period Cash FlowM
Total Cashflows From Investing Activities3.3 M
  

Hadasit Bio Relative Risk vs. Return Landscape

If you would invest  3,500  in Hadasit Bio on November 29, 2025 and sell it today you would earn a total of  720.00  from holding Hadasit Bio or generate 20.57% return on investment over 90 days. Hadasit Bio is generating 1.0029% of daily returns and assumes 8.9592% volatility on return distribution over the 90 days horizon. Simply put, 80% of stocks are less volatile than Hadasit, and 80% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Hadasit Bio is expected to generate 11.93 times more return on investment than the market. However, the company is 11.93 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.11 per unit of risk.

Hadasit Bio Target Price Odds to finish over Current Price

The tendency of Hadasit Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 42.20 90 days 42.20 
about 17.72
Based on a normal probability distribution, the odds of Hadasit Bio to move above the current price in 90 days from now is about 17.72 (This Hadasit Bio probability density function shows the probability of Hadasit Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon Hadasit Bio has a beta of 0.65. This usually indicates as returns on the market go up, Hadasit Bio average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Hadasit Bio will be expected to be much smaller as well. Additionally Hadasit Bio has an alpha of 0.9925, implying that it can generate a 0.99 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta).
   Hadasit Bio Price Density   
       Price  

Predictive Modules for Hadasit Bio

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Hadasit Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
33.2442.2051.16
Details
Intrinsic
Valuation
LowRealHigh
26.2135.1744.14
Details
Naive
Forecast
LowNextHigh
28.2737.2346.19
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-103.2238.7045.80
Details

Hadasit Bio Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Hadasit Bio is not an exception. The market had few large corrections towards the Hadasit Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Hadasit Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Hadasit Bio within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
0.99
β
Beta against Dow Jones0.65
σ
Overall volatility
6.51
Ir
Information ratio 0.08

Hadasit Bio Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Hadasit Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Hadasit Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Hadasit Bio is not yet fully synchronised with the market data
Hadasit Bio is way too risky over 90 days horizon
Hadasit Bio appears to be risky and price may revert if volatility continues
Hadasit Bio has high likelihood to experience some financial distress in the next 2 years
Hadasit Bio has accumulated about 18.14 M in cash with (2.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.64.
Roughly 75.0% of the company shares are held by company insiders

Hadasit Bio Fundamentals Growth

Hadasit Stock prices reflect investors' perceptions of the future prospects and financial health of Hadasit Bio, and Hadasit Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Hadasit Stock performance.

About Hadasit Bio Performance

By analyzing Hadasit Bio's fundamental ratios, stakeholders can gain valuable insights into Hadasit Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Hadasit Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Hadasit Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. HBL HADASIT is traded on Tel Aviv Stock Exchange in Israel.

Things to note about Hadasit Bio performance evaluation

Checking the ongoing alerts about Hadasit Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Hadasit Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Hadasit Bio is not yet fully synchronised with the market data
Hadasit Bio is way too risky over 90 days horizon
Hadasit Bio appears to be risky and price may revert if volatility continues
Hadasit Bio has high likelihood to experience some financial distress in the next 2 years
Hadasit Bio has accumulated about 18.14 M in cash with (2.1 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.64.
Roughly 75.0% of the company shares are held by company insiders
Evaluating Hadasit Bio's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Hadasit Bio's stock performance include:
  • Analyzing Hadasit Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Hadasit Bio's stock is overvalued or undervalued compared to its peers.
  • Examining Hadasit Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Hadasit Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Hadasit Bio's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Hadasit Bio's stock. These opinions can provide insight into Hadasit Bio's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Hadasit Bio's stock performance is not an exact science, and many factors can impact Hadasit Bio's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Hadasit Stock analysis

When running Hadasit Bio's price analysis, check to measure Hadasit Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hadasit Bio is operating at the current time. Most of Hadasit Bio's value examination focuses on studying past and present price action to predict the probability of Hadasit Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hadasit Bio's price. Additionally, you may evaluate how the addition of Hadasit Bio to your portfolios can decrease your overall portfolio volatility.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites